In the same studies, users saw a small decrease in BMI (around 0.5 points) and a slight reduction in waist size (about 0.4 inches)
IGFBP-3 (IGF binding protein 3)
WHAT'S CHANGING UHC Coverage Outlook for 2026 Good news: UHC and OptumRx are maintaining Wegovy on 2026 formularies for plans that currently cover obesity medications
If the results remain positive, researchers hope to work with the FDA to approve GLP-1 medications for addiction treatment
Radiesse Plus stimulates collagen production for firmer, more radiant skin over several months
With our advertising service, you receive not just leads, but qualified, retained clients, complete with all necessary secondary documentation, streamlining your intake process and positioning your firm for success in the competitive litigations